The function of miR-masking oligonucleotides was first described in breast cancer, where the inhibition of the tumor suppressor TP63 could be prevented by miR-196a2 masking oligonucleotide, reducing tumor cell proliferation [110]. This evidence concerns the gene TP63 and neoplasm.